Jefferies Group LLC Reaffirms Buy Rating for Abeona Therapeutics Inc (ABEO)

Abeona Therapeutics Inc (NASDAQ:ABEO)‘s stock had its “buy” rating reaffirmed by research analysts at Jefferies Group LLC in a research note issued on Friday. They presently have a $11.00 target price on the biopharmaceutical company’s stock. Jefferies Group LLC’s price objective suggests a potential upside of 117.82% from the company’s previous close.

Other research analysts have also issued reports about the stock. HC Wainwright set a $20.00 target price on shares of Abeona Therapeutics and gave the company a “buy” rating in a research note on Monday, February 6th. Rodman & Renshaw reiterated a “buy” rating and issued a $20.00 target price (up from $17.00) on shares of Abeona Therapeutics in a research note on Tuesday, February 7th. Zacks Investment Research upgraded shares of Abeona Therapeutics from a “hold” rating to a “buy” rating and set a $5.25 target price on the stock in a research note on Tuesday, January 31st. Maxim Group set a $14.00 target price on shares of Abeona Therapeutics and gave the company a “buy” rating in a research note on Wednesday, January 18th. Finally, Cantor Fitzgerald set a $21.00 target price on shares of Abeona Therapeutics and gave the company a “buy” rating in a research note on Monday, December 12th. One analyst has rated the stock with a sell rating and six have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $15.18.

Analyst Recommendations for Abeona Therapeutics (NASDAQ:ABEO)

Abeona Therapeutics (NASDAQ:ABEO) remained flat at $5.05 during midday trading on Friday. The stock had a trading volume of 190,008 shares. The company’s market capitalization is $201.79 million. Abeona Therapeutics has a one year low of $2.27 and a one year high of $9.44. The firm has a 50 day moving average of $5.18 and a 200 day moving average of $5.70.

Your IP Address:

A number of hedge funds have recently bought and sold shares of the company. Knoll Capital Management LP bought a new stake in Abeona Therapeutics during the third quarter valued at about $8,036,000. Perceptive Advisors LLC acquired a new stake in shares of Abeona Therapeutics during the fourth quarter valued at $4,085,000. Kavi Asset Management LP raised its stake in shares of Abeona Therapeutics by 477.6% in the fourth quarter. Kavi Asset Management LP now owns 365,600 shares of the biopharmaceutical company’s stock valued at $1,773,000 after buying an additional 302,300 shares during the period. Opaleye Management Inc. raised its stake in shares of Abeona Therapeutics by 300.0% in the fourth quarter. Opaleye Management Inc. now owns 400,000 shares of the biopharmaceutical company’s stock valued at $1,940,000 after buying an additional 300,000 shares during the period. Finally, Highbridge Capital Management LLC acquired a new stake in shares of Abeona Therapeutics during the third quarter valued at $1,591,000. Institutional investors own 17.79% of the company’s stock.

About Abeona Therapeutics

Abeona Therapeutics, Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc, is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Company’s lead programs are ABO-101 (AA9 NAGLU) and ABO-102 (scAAV9 SGHG), adeno-associated virus (AAV)-based gene therapies for Sanfilippo syndrome (Mucopolysaccharidosis (MPS) IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians.

5 Day Chart for NASDAQ:ABEO

Receive News & Ratings for Abeona Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abeona Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Nike Suspends Relationship with Maria Sharapova
Nike Suspends Relationship with Maria Sharapova
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Ron Washington Leaves Texas Rangers Due to an Affair
Ron Washington Leaves Texas Rangers Due to an Affair
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Tony Stewart Case Going to the Grand Jury
Tony Stewart Case Going to the Grand Jury
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder


Leave a Reply

 
© 2006-2017 Web Breaking News.